Farmaindustria And Spanish Govt Still Talking

4 August 1996

As European business winds down for the traditional August break, the Spanish pharmaceutical industry association, Farmaindustria, and the Spanish Health Ministry were still in negotiations regarding the limits on pharmaceutical spending over the next two years (Marketletters passim).

The latest proposals of both the Health Ministry and Farmaindustria are outlined below. As previously reported, Farmaindustria wants to include hospital debt for drug supplies in the negotiations, along with pricing freedom for non-reimbursable pharmaceutical products.

As the Marketletter went to press, no further information on the negotiations was available. It would appear that the two sides will have to pick up their talks after the summer break.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight